New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2014
10:35 EDTNSR, GMCR, AEGR, CHTP, ECYTOptions with decreasing implied volatility: CHTP ECYT NSR GMCR AEGR
News For CHTP;ECYT;NSR;GMCR;AEGR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
07:28 EDTAEGRLeerink to hold a roundtable
Subscribe for More Information
September 30, 2014
10:02 EDTECYTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:07 EDTNSRNeuStar to build miltiple Tbps DDoS mitigation platform
Subscribe for More Information
05:28 EDTECYTEndocyte downgraded to Hold from Buy at Brean Capital
Brean Capital downgraded Endocyte to Hold saying it views the company's data for vintafolide as "marginal."
September 29, 2014
07:03 EDTNSRNeuStar plans to send report to FCC this week, NY Times says
NeuStar (NSR) plans this week to send the Federal Communications Commission a 45-page report done by former secretary of the Department of Homeland Security, Michael Chertoff, New York Times says. The report discusses national security concerns should NeuStar lose its $446M phone call routing contract to Ericsson (ERIC), as recommended to the FCC by a private phone-industry panel, the paper adds. Reference Link
06:27 EDTECYTEndocyte to host conference call
Subscribe for More Information
September 28, 2014
14:12 EDTECYTEndocyte says Phase 2b TARGET trial results show improved survival
Endocyte announced that the small molecule drug conjugate, SMDC, vintafolide in combination with docetaxel extended overall survival for patients with folate receptor positive recurrent non-small cell lung cancer, NSCLC, compared to patients receiving monotherapy docetaxel in its TARGET Phase 2b clinical trial. The late-breaking TARGET trial data will be presented today at the European Society for Medical Oncology Congress, ESMO, by Rohit Lal, M.D., consultant medical oncologist at Guys and St Thomas' Hospital and an Honorary Consultant Medical Oncologist for Kings College Hospital, London.
September 26, 2014
11:09 EDTAEGRAegerion management to meet with Leerink
Subscribe for More Information
06:13 EDTGMCRKeurig Green Mountain implied volatility of 31 at lower end of index mean range
September 25, 2014
08:59 EDTAEGRSummer Street chief scientific officer holds an analyst/industry conference call
Subscribe for More Information
08:33 EDTGMCRGreen Mountain's Keurig 2.0 launch trends positive, says Longbow
Subscribe for More Information
September 23, 2014
09:04 EDTNSRNeuStar partners with Adelphic, NinthDecimal, Voltari
Neustar (NSR) announced three new partnerships with mobile media leaders that will allow marketers to reach consumers across smartphones and tablets. Its partnerships with Adelphic, NinthDecimal, and Voltari (VLTC) improve a marketerís ability to target and personalize interactions with mobile consumers.
September 22, 2014
07:17 EDTGMCRKeurig Green Mountain favorable antitrust ruling was expected, says KeyBanc
Subscribe for More Information
September 19, 2014
17:22 EDTGMCRJudge denies JBR motion blocking sales of Keurig 2.0 brewer, Bloomberg reports
Subscribe for More Information
16:13 EDTGMCRJudge denies JBR motion blocking sales of Keurig 2.0 brewer, Bloomberg reports
06:08 EDTGMCRKeurig Green Mountain implied volatility of 29 at lower end of index mean range
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use